Tatton Consulting supported Birmingham-based pharmaceutical formulation company Mesox in its successful application to Innovate UK Smart grants: January 2023, awarded £274,744 by Innovate UK for the project ASD3MAP: Amorphous Solid Dispersion Digital Design and Manufacturing Platform for rapid and resource-efficient development of bioavailable medicines. The total Innovate UK grant across all project partners was £357,249.
About the funded R&D project
Many promising drug molecules fail on bioavailability, and amorphous solid dispersions are a route around that. Developing them is slow and material-intensive. MESOX, with Aston University, spends 18 months refining molecular dynamics models and integrating commercial material science and simulation tools into an in-silico formulation development platform, shifting the work from bench trials to computation.
Award details
- Grant to Mesox: £274,744
- Total project grant (all partners): £357,249
- Competition: Innovate UK Smart grants: January 2023
- Competition year: 2023/24
- Project: ASD3MAP: Amorphous Solid Dispersion Digital Design and Manufacturing Platform for rapid and resource-efficient development of bioavailable medicines
- Sector: Pharmaceutical formulation
- Independent verification: Innovate UK funded projects transparency dataset (UKRI), published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title are taken from Innovate UK’s published record of funded projects.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
